Actionable news
All posts from Actionable news
Actionable news in NVCR: NovoCure Ltd,

10 Stocks Moving In Monday's Pre-Market Session


  • Novocure Ltd NVCR shares rose 23.5 percent to $9.99 in pre-market trading. Novocure announced that the long-term survival analysis of all 695 patients enrolled in its phase 3 pivotal EF-14 trial in newly diagnosed glioblastoma confirms superior progression free and overall survival seen in the trial’s interim Analysis.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.


  • Amarin Corporation plc (ADR) AMRN shares fell 12 percent to $2.79 in pre-market trading as the company disclosed that its REDUCE-IT cardiovascular outcomes study of Vascepa will continue as planned at recommendation of the independent data monitoring committee.

© 2016 Benzinga does not provide investment advice. All rights reserved.